chrisvoncsefalvay/vaers-outcomes huggingface dataset:
terrible deep pain in my rib cage; arm was extremely sore for about 4 days; This spontaneous case was reported by a pharmacist (subsequently medically confirmed) and describes the occurrence of MUSCULOSKELETAL CHEST PAIN (terrible deep pain in my rib cage) and LIMB DISCOMFORT (arm was extremely sore for about 4 days) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 26-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Dec-2020, the patient experienced MUSCULOSKELETAL CHEST PAIN (terrible deep pain in my rib cage) and LIMB DISCOMFORT (arm was extremely sore for about 4 days). At the time of the report, MUSCULOSKELETAL CHEST PAIN (terrible deep pain in my rib cage) and LIMB DISCOMFORT (arm was extremely sore for about 4 days) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Information has been received from a registered nurse referring to a 16 year old female patient. There was no concurrent condition or medical history reported. On 24-MAR-2016 the patient was inadvertently administered a dose of the adult formulation of VAQTA (lot # L031196, expiration date 05-FEB-2017) (dosage and strength unknown) intramuscularly. This was outside the labeled recommendation in the VAQTA prescribing information. This was the only dose of VAQTA this patient had ever been administered. No adverse effect was required. Additional information has been requested.
Rash that started around the injection area; Rash that spread to other parts of his body; redness on both his hands; rash on both his hands; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (Rash that started around the injection area), RASH (Rash that spread to other parts of his body), ERYTHEMA (redness on both his hands) and RASH (rash on both his hands) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for an unknown indication.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE RASH (Rash that started around the injection area), RASH (Rash that spread to other parts of his body), ERYTHEMA (redness on both his hands) and RASH (rash on both his hands). At the time of the report, VACCINATION SITE RASH (Rash that started around the injection area), RASH (Rash that spread to other parts of his body), ERYTHEMA (redness on both his hands) and RASH (rash on both his hands) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to MOD21-066021 (E2B Linked Report).; Sender's Comments:  MOD21-066021:crosslinked to patient case
pt recvd vax & c/o throat swelling; given EPI immediate response-tightness & swelling went away; DPH given;
Tested positive for COVID at NH. NH could not house patient, no COVID unit. Pt asymptomatic. "Believes he has been vaccinated" but this is not confirmed in notes. No treatment required. Pt was placed in NH and discharged.
I got really sick that night till Wed afternoon, fever, chills, body aches, muscle aches, chills, hot, cold, weak.
Injection of Daptacel was administered on 4/21/2003. Given IM in right shoulder. Area of 9cm x 7cm. Red, swollen, itchy, sore. Began morningn after injection. Pt placed on Keflex and Zyrtec. Pt recheck on 4/23. Area had improved.
Shot was at 4:30 pm , I went to sleep at 9:00 pm, I woke up before dawn with a burning itch on both arms.  By noon both forearms were covered.  within 2 days there were splotches on chest back and both legs.  rash grew from red puffy splotches into very painful blisters.  everywhere it was hurt to touch.  blisters that popped caused scarring.  Cortisone cream,  antihistamine, Neosporin,  and Acetaminophen it eventually subsided between  13-16 days
neck pain; fatigue; nausea; chills; headache; pain around the injection site; arthralgia; general myalgias; This spontaneous case was reported by a physician and describes the occurrence of NECK PAIN (neck pain), VACCINATION SITE PAIN (pain around the injection site), ARTHRALGIA (arthralgia), MYALGIA (general myalgias) and FATIGUE (fatigue) in a 35-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 25-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, the patient experienced VACCINATION SITE PAIN (pain around the injection site), ARTHRALGIA (arthralgia) and MYALGIA (general myalgias). On an unknown date, the patient experienced NECK PAIN (neck pain), FATIGUE (fatigue), NAUSEA (nausea), CHILLS (chills) and HEADACHE (headache). At the time of the report, NECK PAIN (neck pain), VACCINATION SITE PAIN (pain around the injection site), ARTHRALGIA (arthralgia), MYALGIA (general myalgias), NAUSEA (nausea), CHILLS (chills) and HEADACHE (headache) had resolved and FATIGUE (fatigue) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant medications were provided No Treatment information provided   This case was linked to MOD-2021-045901 (Patient Link).
more of a side effect. Developed a genital herpes lesion that night. The same thing happened when I got my Shingrix shot. Will a 3 to 5 day series of Valtrex treatment affect the Covid-19 vaccine effectiveness?
Information has been received from a certified nurse midwife concerning a 23 year old pregnant female who is bipolar and has a history of depression, anxiety, abnormal pap test and had a loop electrosurgical excision procedure. On 02-NOV-2007 the patient was vaccinated IM with the first dose of GARDASIL vaccine (lot # 658563/1063U). On 09-JAN-2008 the patient was vaccinated IM with the second dose of GARDASIL vaccine (lot #659437/1266U). The last menstrual period was reported to be on 10-JAN-2008. An urine pregnancy test was performed with positive results. On 12-JAN-2008 a maternal serum alpha-fetoprotein test was performed within normal results. On 05-MAR-2008 an ultrasound was performed (NP). It was also reported that this is the patient's first pregnancy. The estimated delivery date is 16-OCT-2008. The certified nurse midwife reported she wishes to register the patient on the pregnancy registry. Follow-up information has been received from certified nurse midwife concerning the patient, who was also reported to be a smoker with no history of previous pregnancies. On 01-MAY-2008,  MSAFP screening test as performed and results were within normal limits. It was reported he mother developed oligohydramnios during the pregnancy. On 21-OCT-2008, 41.1 weeks from the last menstrual period, the patient delivered a normal male baby who weighted 7 pounds and 13.8 ounces. His length was 19 feet. His Apgar score was assessed to be 8/9. No complications occurred during the labor. No further information is available.
Sharp stabbing pains weakness in my right hip, and tingling sensation in my right upper leg.  Lower back tightness and pain.  Recently my leg pain has turned to burning, ripping pain.
COVID 19; COVID 19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 48-year-old male patient received BNT162b2 (BNT162B2), on 09Aug2022 at 12:00 as dose number unknown, single (Batch/Lot number: unknown) at the age of 47 years for covid-19 immunisation. The patient's relevant medical history included: "Immunocompromised" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Negative, notes: Covid Rebound after two days of testing negative. Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical course: Known allergies: No. Anti viral details: Product: COVID 19 Treatment, Brand: Paxlovid, Treatment Start Date: 12Jan2023, Treatment Stop Date: 16Jan2023.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Next morning after injection the site was red, sore and beginning to swell and continued being more painful throughout the day. Was seen by MD and was given Allegra and pain med. Feels "much better" 10/25/02 today. Arm, shoulder, and neck pain.
Patient slumped over in chair was not feeling well and possible having trouble breathing. We called 911 and they came and checked her blood pressure and blood sugar. All were normal. Patient did not leave with the ambulance. She went home and ate something and was feeling much better.
anaphylactically allergic; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP).  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ANAPHYLACTIC REACTION (medically significant), outcome "unknown", described as "anaphylactically allergic". Therapeutic measures were taken as a result of anaphylactic reaction.  The lot number for bnt162b2 was not provided and will be requested during follow up.
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a female patient of unknown age. No information was provided regarding concomitant medications, concurrent conditions or medical history. In 2007, the patient was inoculated with ZOSTAVAX at a hospital as recommended for routine adult health maintenance and for the prevention of shingles (dose, lot, and route # not provided). The vaccine did not prevent shingles as intended and the patient subsequently contracted a persistent strain condition of herpes zoster. In 2011, the patient was treated at a physician's office for a persistent and severe vesicular rash, which was diagnosed as herpes zoster, or shingles. As a direct and proximate result of ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the events was unknown. Causality assessment was related. Additional information has been requested.
On evening of 10/15/19 patient developed itching, warmth, swelling and redness of left deltoid.  parent administered cool compress, ibuprofen and benadryl per doctor's instructions. The following day (10/16/19), swelling had not improved. Mom gave another dose of ibuprofen and brought child to be seen by me.  On exam left upper arm with firm, indurated swelling overlying entire deltoid (@10cm x 8cm).  very warm to touch, slightly tender.  I advised parent to continue with cool compresses and ibuprofen.  Dose of diphenhydramine given in office. Because of degree of warmth and swelling, I treated for cellulitis with antibiotic (augmentin).  Within 12-18 hours of starting antibiotic swelling, induration, warmth had begun to decrease.
Elevated blood pressure starting approximately 6 hours after vaccine injection was received. My normal BP 99-110/60-75.  BP from 6pm on the day of vaccine 134-150/80-91.  I take my BP twice a day since having COVID in July 2021.  Slightly elevated temp (99°)  My normal temp is 96.3-97.6  The following, additional symptoms began to manifest approximately 12 hours after vaccine injection was adminstered. Body aches Sore throat Chest congestion Headache
Swelling, redness, heat pain from elbow to shoulder. Worse 24 hours later. Swelling now below elbow. Redness also on underside of upper arm. I went to the ED and recommended treatment was NSAIDS and cold compress. Symptoms unresolved and worsened, waiting for call back from provider.
Information has been received from a lawyer regarding a case in litigation concerning a male patient (age unknown). The patient's medical history, concurrent conditions and concomitant medication use were not provided. On or about 01-NOV-2013, the patient was vaccinated with ZOSTAVAX, (lot# and route unknown) as recommended for routine adult health maintenance and for the prevention of shingles.  The vaccine did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster. On or about 01-APR-2015, the patient was treated by a physician for a vesicular rash, which was diagnosed as herpes zoster or shingles.  On or about 11-DEC-2017, the patient sought subsequent treatment by another physician for ongoing and worsening episodes of shingles outbreaks. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment.  As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
Information has been received through the pregnancy registry from a nurse practitioner concerning a 15 year old female who was vaccinated with a dose of varicella virus vaccine live when she was approx 4-5 weeks pregnant. An ultrasound showed a gastroschisis. A repeat ultrasound was scheduled. At the time of the report, the pt was 18 weeks gestation. The vaccine was given at another physician, and she does not have any other information on the administration. Gastroschisis was noted to be a congenital anomaly. Additional information has been requested.
This child died unexpectedly the following morning in her sleep. She has been diagnosed with SUDC (sudden unexplained death of a child). Preliminary autopsy did not uncover any medical issues or problems. There is further testing being done and it may be a few months before all tests are done and final report is available.  I do not submit this event as evidence of the cause of this child's death. However, I need to report this event as it is not clear whether or not the vaccine(s) are related. I had initially planned to wait until final autopsy results were available, but that is taking very long and I wanted to make this report. I submit it today and can provide final autopsy report when I receive it.
I did not have an adverse reaction to the vaccine. I began not feeling well on 02/17/2023 with cold like symptoms. I tested positive for COVID-19 on 02/19/2023. I contacted an urgent care to get the prescription PAXLOVID but did not take. I only took TYLENOL to help with my symptoms. As of today, I have a cough and I feel like I get respiratory illnesses easier.
Muscle pain at right arm and in the center of chest; chest pain; pain in the RIGHT arm; Blood pressure was 161/120.; Soreness at the injection site; This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 79-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 13th June 2022, the patient received the 1st dose of Shingrix (intramuscular). On 13th June 2022, less than a day after receiving Shingrix, the patient experienced injection site pain. On 14th June 2022, the patient experienced muscle pain, chest pain, pain in arm and increased blood pressure. On 16th June 2022, the outcome of the muscle pain, chest pain, pain in arm and increased blood pressure were recovered/resolved. On 18th June 2022, the outcome of the injection site pain was recovered/resolved.   The reporter considered the injection site pain to be related to Shingrix. It was unknown if the reporter considered the muscle pain, chest pain, pain in arm and increased blood pressure to be related to Shingrix.     Additional Information: GSK Receipt Date: 23-JUN-2022 Reporter's comment: The patient self reported this case. The patient received dose of Shingrix vaccine into left arm and a couple hours later he had soreness at the injection site. The patient stated that on next day after vaccination his right arm had muscle pain and so did the center of his chest. The patient also reported his blood pressure was 161/120.  The pain in the right arm, chest and elevated blood pressure continued into the next day (15th June 2022).  The patient experienced muscle pain, chest pain, pain in arm and increased blood pressure events one day after the vaccination. The patient's HCP (Health Care Professional) had told him if he ever had elevated blood pressure to take an extra Clonidine tablet. The patient said all symptoms (right arm pain, chest pain and elevated blood pressure) resolved completely by 16th June 2022. The reporter did not consent to follow-up.
Pt received DTP and developed temp of 103.5 and a "weird cry for a prolonged period.
I am a medical physician, Radiation oncologist, mother of 6 (all five before completely vaacinated).  I never thought twice about any harmful effects of vaacines and as a MD, naturally vaacinated my baby according to schedule.  He was bright, happy, talkative with constant babbling, engaging with older siblings, etc.  Immediately after the vaacine (Dtap and MMR) he was fussy and withdrawn.  I figured that might be normal for a few hours or a day but it got worse.  NO LANGUAGE OR BABBLING WHATSOEVER.  It was literally like our little boy was just gone...like he was just a shell.  No interaction, eye contact, developmental milestones, personality...nothing!  He had fevers and they resolved after several days but he remained withdrawn for 3 weeks.  Then I researched this situation and provided extra vitamins in his formula (who knows if that had any impact) but he began, as if developing from the beginning, from scratch, to slowly reengage for periods of time.  Like we would all get short glimpses of the child we knew.  Then more and more, he just seemed to recover and now he is meeting all neurologic/developmental milestones and seems at 21 months to be "normal."  I finally have the time and felt compelled to add this to your data base all this time later.  It was so scary and really devastating and fortunately short lived.  I will not vaacinate him any further.  The risk far outweighs the potential benefit in this sweet baby boy!  As a medical licensed, practicing full time physican, mother of 5 other vaacinated children, non-conspirist type person, and medical director of the Care Center,  I feel very strongly that I am qualified to say and a reliable testimony to say that this reaction was absolutely the cause of something in one of those vaacines.   As a parent it was terrifying and profound.  I have no idea why he recovered his functioning but our family is so thankful he did.  It may be helpful to know that he was delivered by C-section because of a fibroid I had (nothing developmentally wrong with him), 3 weeks early.   Also two of my kids are my step kids and it may be helpful to know that one of them (the boy, now 17 years old) has high functioning autism.  I don't know if either of these factors predisposed patient to these reactions or not.  I received no vaacinations whatsoever during pregnancy.
Raised area; Redness at the injection site; This spontaneous case was reported by a pharmacist and describes the occurrence of INJECTION SITE SWELLING (Raised area) and INJECTION SITE ERYTHEMA (Redness at the injection site) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INJECTION SITE SWELLING (Raised area) and INJECTION SITE ERYTHEMA (Redness at the injection site). At the time of the report, INJECTION SITE SWELLING (Raised area) and INJECTION SITE ERYTHEMA (Redness at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was reported.  No treatment medication was reported.
PT WITH AUTISTIC, WAS STUCK WITH NEEDLE FOR  VACCINE, BUT MOVED SUDDENLY AND THE VACCINATOR REMOVED THE NEEDLE FOR SAFETY CONCERNS AND DID NOT RECD VACCINE. MOM WAS REFERRED TO PEDS FOR THE VACCINE.
Swollen sore lymph node in left armpit and left supraclavicular lymph node
The attendee received his 1st Pfizer dose on May 12, 2021 (at the same site) and his second dose on May 27, 2021. So, 15 days between doses and the 2nd Pfizer vaccination is supposed to be given at least 21 days  42 days after the first. Attendee did not have his vaccination card with him when vaccinated for his second dose. The error was caught the next day when he returned to have his vaccination card filled out.  The attendee did not have any adverse reaction to the vaccine while at the site.
Hoarseness in voice; Muscles in her face were swollen; This is a spontaneous case from the , initially reported by other non-health professional to The Agency (reference number: SEQW20-00288) on 13-Apr-2020, concerning a 46-year-old female patient.   The patient medical history and concomitant medications were not reported.  On 30-Mar-2020, the patient was administered Flucelvax QIV [Influenza vaccine, subunit influenza virus vaccine polyvalent; dose: 0.5 mL, route of administration: intramuscular, anatomical location: deltoid, batch number and expiry date: not reported] for influenza prophylaxis.  On an unspecified date in 2020, unknown time after vaccination, muscles in the patient's face were swollen and she had hoarseness in her voice.  At the time of initial report, the outcome of all events was unknown.  The case was assessed as non-serious.  The reporter did not provide causality assessment.  Company comment: The patient developed dysphonia and swelling face unknown amount of time after vaccination with Flucelvax QIV. Chronology needs more clarification. The patient medical history and concomitant medications were not reported. With information available, causal role of the suspect product is assessed as possibly related.; Sender's Comments: The patient developed dysphonia and swelling face unknown amount of time after vaccination with Flucelvax QIV. Chronology needs more clarification. The patient medical history and concomitant medications were not reported. With information available, causal role of the suspect product is assessed as possibly related.
PT WAS DUE FOR 2ND MODERNA AND RECIEVED PFIZER.
I contracted COVID-19 on 07/21/2022 with symptoms of headache, runny nose, cough, congestion, and fatigue. I was prescribed PAXLOVID on 07/22/2022. I was ill for 2 days before my symptoms began to resolve. I am fully recovered with no lingering symptoms.
Fever, nausea , disoriented, ringing in my ears, forgetfulness for months. Brain tracers, vision problems.
Approx 20 mins after receiving vaccine experienced chest tightness and SOB. Symptoms lasted ~ 1 hr. The next day had a little chest tightness and slight SOB. Was evaluated in ED.